Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

AcelRx completes human factors study for painkiller DSUVIA

Monday, April 16, 2018 7:33
% of readers think this story is Fact. Add your two cents.

AcelRx Pharmaceuticals Inc (Nasdaq:ACRX), a pharmaceutical group that develops therapies for the treatment of acute pain, has finished its human factors study, which was designed to show the effectiveness of its painkiller DSUVIA’s usage directions.

The completion of the human factors study marks the last step required to prepare AcelRx’s DSUVIA’s new drug application, which is set to be resubmitted to the US Food and Drug Administration in the second quarter of this year.

In morning trade, AcelRx shares rose 4.7% to US$2.35.

“This study was the first of our key 2018 milestones outlined on our year-end earnings call,” said Vince Angotti, chief executive of AcelRx, in a statement. “We remain focused on the achievement of each of these key milestones, which we believe will enable 2018 to be a transformational year for AcelRx.”

DSUVIA consists of 30mcg of sufentanil in small tablets, taken under the tongue, which are delivered via a disposable, pre-filled single dose applicator. The drug is intended to be used to manage acute pain in emergency medicine, outpatient surgery and surgeries when only a short stay is required.

The completion of the human factors study was recommended by the FDA after AcelRx submitted recommended changes to the directions accompanying DSUVIA.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories


Top Global

Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.